Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study

Overview of attention for article published in The Journal of Headache and Pain, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 11,852 followers.

RT @EHF_Official: Predicting response to anti-CGRP mABs. This study found that older age, fewer prior treatment failures and no past hist…

@Anazuresky2 参考になりました😊✨これですね https://t.co/Oqr5zUzXnD これだと、リウマチの既往がなくて、高齢の予防薬への反応性が比較的良い人に使えば効きやすいよとなるんですかね

RT @EHF_Official: Predicting response to anti-CGRP mABs. This study found that older age, fewer prior treatment failures and no past hist…

RT @EHF_Official: Predicting response to anti-CGRP mABs. This study found that older age, fewer prior treatment failures and no past hist…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.